Cocrystal Pharma, Inc. (COCP): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-30, first reflected in a filing dated 2018-03-21; 1-for-12, first reflected in a filing dated 2022-11-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Figures left out. The filed Shares Outstanding for the years ended 2013-12-31, 2014-12-31 are not shown: shares outstanding out of scale with weighted shares; zero share count. That usually means the filing tagged the figure in the wrong unit.

13.78M

As of 2025-12-31

13.79M

As of 2026-06-30

+19.2%

3-year compound annual growth

2010-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period ended	Shares Outstanding	Change YoY	Source filing
2025-12-31	13.78M	+35.5%	2026-03-31, Balance as of period end
2024-12-31	10.17M	0.0%	2026-03-31, Balance as of period end
2023-12-31	10.17M	+24.9%	2025-03-31, Balance as of period end
2022-12-31	8.14M	0.0%	2024-03-28, Balance as of period end
2021-12-31	8.14M	n/c	2023-03-29, Balance as of period end
2020-12-31	70.44M	n/c	2022-03-23, Balance as of period end
2019-12-31	35.15M	+17.4%	2021-03-17, Balance as of period end
2018-12-31	29.94M	+23.3%	2020-03-27, Balance as of period end
2017-12-31	24.27M	+2.0%	2019-04-01, Balance as of period end
2016-12-31	23.80M	n/c	2018-03-21, Balance as of period end
2015-12-31	694.40M	n/a	2017-03-31, Balance as of period end
No annual figure between 2012-12-31 and 2015-12-31.
2012-12-31	63.14M	+14.4%	2014-03-31, Balance as of period end
2011-12-31	55.18M	+23.3%	2013-04-01, Balance as of period end
2010-12-31	44.75M	n/a	2012-04-16, Balance as of period end